About Focus Pipeline Investors Contact Building Bridges in Medical Dermatology We advance innovative clinical research evaluating novel treatments for rare dermatologic diseases with limited options. Our Focus At our core, we focus on supporting people living with some of the most serious conditions in medical dermatology. Learn more Strategic Pipeline We are positioned to expand our clinical development programs to target broader conditions with these novel treatments in the years ahead. Learn more About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Investor Relations Timber Pharmaceuticals Overview Timber Pharmaceuticals is building a rare and orphan dermatology company that focuses on mitigating the cost, risk, and time of drug development by leveraging the Orphan Drug pathway for conditions with no FDA Approved treatments. The company's investigational therapies utilize proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. Timber is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas in tuberous sclerosis complex (TSC), and scleroderma. Investor Overview SEC Filings Press Releases Corporate Governance Events & Presentations Contact Investor Relations Stock Quote Investor Presentation September 2021 Click to Download Click to Submit Incident Report About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Investor Relations Choose an option Investor Overview SEC Filings Press Releases Corporate Governance Events & Presentations Contact Investor Relations Stock Quote About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC

About Focus Pipeline Investors Contact Legal Notice PLEASE READ THIS AGREEMENT CAREFULLY BEFORE ACCESSING THIS WEBSITE. THIS NOTICE IS MADE A PART OF AND INCORPORATED INTO THE TERMS OF USE ENTERED INTO BY AND BETWEEN YOU AS A USER OF THE PAXMEDICA.COM SITE ("USER" OR "YOU") AND PAXMEDICA ("PAXMEDICA" OR "WE"). BY ACCESSING AND/OR USING THE WEBSITE, YOU AGREE THAT YOU HAVE READ, UNDERSTAND, AND AGREE TO THE TERMS OF USE. Disclaimer All statements and expressions are the sole opinion of the Company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. About Focus Pipeline Investors Contact Legal Notice | © 2020 by Timber Pharmaceuticals LLC